Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

RSS FeedsGilead`s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
(Reuters Business)

 
 

3 june 2020 19:38:18

 
Gilead`s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
(Reuters Business)
 
Gilead Sciences Inc`s potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday.


 
45 viewsCategory: Business
 
Walmart removes firearms, ammunition from floor display as protests rage in U.S.
(Reuters Business)
Heads of U.S. automakers, other Michigan companies condemn racism, injustice
(Reuters Business)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten